Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Download
Faster access than browser!
 

5-HT receptor and Selective serotonin reuptake inhibitor

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between 5-HT receptor and Selective serotonin reuptake inhibitor

5-HT receptor vs. Selective serotonin reuptake inhibitor

5-hydroxytryptamine receptors or 5-HT receptors, or serotonin receptors, are a group of G protein-coupled receptor and ligand-gated ion channels found in the central and peripheral nervous systems. Selective serotonin reuptake inhibitors (SSRIs) are a class of drugs that are typically used as antidepressants in the treatment of major depressive disorder and anxiety disorders.

Similarities between 5-HT receptor and Selective serotonin reuptake inhibitor

5-HT receptor and Selective serotonin reuptake inhibitor have 27 things in common (in Unionpedia): Agomelatine, Agonist, Antidepressant, Blood vessel, Buspirone, Cognition, Cyclic adenosine monophosphate, Fluoxetine, Ligand (biochemistry), MDMA, Migraine, Mirtazapine, Nefazodone, Neurotransmitter, Paroxetine, Partial agonist, Receptor antagonist, Serotonin, Serotonin syndrome, Tramadol, Triptan, Vilazodone, Vortioxetine, 5-HT1A receptor, 5-HT2A receptor, 5-HT3 receptor, 5-HT7 receptor.

Agomelatine

Agomelatine (brand names Valdoxan, Melitor, Thymanax) is an atypical antidepressant developed by the pharmaceutical company Servier.

5-HT receptor and Agomelatine · Agomelatine and Selective serotonin reuptake inhibitor · See more »

Agonist

An agonist is a chemical that binds to a receptor and activates the receptor to produce a biological response.

5-HT receptor and Agonist · Agonist and Selective serotonin reuptake inhibitor · See more »

Antidepressant

Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders.

5-HT receptor and Antidepressant · Antidepressant and Selective serotonin reuptake inhibitor · See more »

Blood vessel

The blood vessels are the part of the circulatory system, and microcirculation, that transports blood throughout the human body.

5-HT receptor and Blood vessel · Blood vessel and Selective serotonin reuptake inhibitor · See more »

Buspirone

Buspirone, sold under the brand name Buspar, is an anxiolytic drug that is primarily used to treat generalized anxiety disorder (GAD).

5-HT receptor and Buspirone · Buspirone and Selective serotonin reuptake inhibitor · See more »

Cognition

Cognition is "the mental action or process of acquiring knowledge and understanding through thought, experience, and the senses".

5-HT receptor and Cognition · Cognition and Selective serotonin reuptake inhibitor · See more »

Cyclic adenosine monophosphate

Cyclic adenosine monophosphate (cAMP, cyclic AMP, or 3',5'-cyclic adenosine monophosphate) is a second messenger important in many biological processes.

5-HT receptor and Cyclic adenosine monophosphate · Cyclic adenosine monophosphate and Selective serotonin reuptake inhibitor · See more »

Fluoxetine

Fluoxetine, also known by trade names Prozac and Sarafem, among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class.

5-HT receptor and Fluoxetine · Fluoxetine and Selective serotonin reuptake inhibitor · See more »

Ligand (biochemistry)

In biochemistry and pharmacology, a ligand is a substance that forms a complex with a biomolecule to serve a biological purpose.

5-HT receptor and Ligand (biochemistry) · Ligand (biochemistry) and Selective serotonin reuptake inhibitor · See more »

MDMA

3,4-Methylenedioxymethamphetamine (MDMA), commonly known as ecstasy (E), is a psychoactive drug used primarily as a recreational drug.

5-HT receptor and MDMA · MDMA and Selective serotonin reuptake inhibitor · See more »

Migraine

A migraine is a primary headache disorder characterized by recurrent headaches that are moderate to severe.

5-HT receptor and Migraine · Migraine and Selective serotonin reuptake inhibitor · See more »

Mirtazapine

Mirtazapine, sold under the brand name Remeron among others, is an atypical antidepressant which is used primarily in the treatment of depression.

5-HT receptor and Mirtazapine · Mirtazapine and Selective serotonin reuptake inhibitor · See more »

Nefazodone

Nefazodone, sold formerly under the brand names Serzone, Dutonin, and Nefadar among others, is an atypical antidepressant which was first marketed by Bristol-Myers Squibb in 1994 but has since largely been discontinued.

5-HT receptor and Nefazodone · Nefazodone and Selective serotonin reuptake inhibitor · See more »

Neurotransmitter

Neurotransmitters are endogenous chemicals that enable neurotransmission.

5-HT receptor and Neurotransmitter · Neurotransmitter and Selective serotonin reuptake inhibitor · See more »

Paroxetine

Paroxetine, also known by trade names including Paxil and Seroxat among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used to treat major depressive disorder, obsessive-compulsive disorder, social anxiety disorder, panic disorder, posttraumatic stress disorder, generalized anxiety disorder and premenstrual dysphoric disorder. It has also been used in the treatment of hot flashes and night sweats associated with menopause. It has a similar tolerability profile to other SSRIs. The common side effects include drowsiness, dry mouth, loss of appetite, sweating, trouble sleeping and delayed ejaculation. It may also be associated with a slightly increased risk of birth defects. The rate of withdrawal symptoms in young people may be higher with paroxetine and venlafaxine than other SSRIs and SNRIs. Several studies have associated paroxetine with suicidal thinking and behavior in children and adolescents. Marketing of the drug began in 1992 by the pharmaceutical company SmithKline Beecham, known since 2000 as GlaxoSmithKline. Generic formulations have been available since 2003 when the patent expired. The United States Department of Justice fined GlaxoSmithKline $3 billion in 2012, including a sum for withholding data on paroxetine, unlawfully promoting it for under-18s and preparing an article, following one of its clinical trials, study 329, that misleadingly reported the drug was effective in treating adolescent depression.

5-HT receptor and Paroxetine · Paroxetine and Selective serotonin reuptake inhibitor · See more »

Partial agonist

In pharmacology, partial agonists are drugs that bind to and activate a given receptor, but have only partial efficacy at the receptor relative to a full agonist.

5-HT receptor and Partial agonist · Partial agonist and Selective serotonin reuptake inhibitor · See more »

Receptor antagonist

A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist.

5-HT receptor and Receptor antagonist · Receptor antagonist and Selective serotonin reuptake inhibitor · See more »

Serotonin

Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine neurotransmitter.

5-HT receptor and Serotonin · Selective serotonin reuptake inhibitor and Serotonin · See more »

Serotonin syndrome

Serotonin syndrome (SS) is a group of symptoms that may occur following use of certain serotonergic medications or drugs.

5-HT receptor and Serotonin syndrome · Selective serotonin reuptake inhibitor and Serotonin syndrome · See more »

Tramadol

Tramadol, sold under the brand name Ultram among others, is an opioid pain medication used to treat moderate to moderately severe pain.

5-HT receptor and Tramadol · Selective serotonin reuptake inhibitor and Tramadol · See more »

Triptan

Triptans are a family of tryptamine-based drugs used as abortive medication in the treatment of migraines and cluster headaches.

5-HT receptor and Triptan · Selective serotonin reuptake inhibitor and Triptan · See more »

Vilazodone

Vilazodone (United States trade name Viibryd) is a serotonergic antidepressant developed by Merck KGaA and licensed by Clinical Data, a biotech company purchased by Forest Laboratories in 2011.

5-HT receptor and Vilazodone · Selective serotonin reuptake inhibitor and Vilazodone · See more »

Vortioxetine

Vortioxetine is an antidepressant medication that is prescribed to treat depression.

5-HT receptor and Vortioxetine · Selective serotonin reuptake inhibitor and Vortioxetine · See more »

5-HT1A receptor

The serotonin 1A receptor (or 5-HT1A receptor) is a subtype of serotonin receptor (5-HT receptor) that binds the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT).

5-HT receptor and 5-HT1A receptor · 5-HT1A receptor and Selective serotonin reuptake inhibitor · See more »

5-HT2A receptor

The mammalian 5-HT2A receptor is a subtype of the 5-HT2 receptor that belongs to the serotonin receptor family and is a G protein-coupled receptor (GPCR).

5-HT receptor and 5-HT2A receptor · 5-HT2A receptor and Selective serotonin reuptake inhibitor · See more »

5-HT3 receptor

The 5-HT3 receptor belongs to the Cys-loop superfamily of ligand-gated ion channels (LGICs) and therefore differs structurally and functionally from all other 5-HT receptors (5-hydroxytryptamine, or serotonin) receptors which are G protein-coupled receptors.

5-HT receptor and 5-HT3 receptor · 5-HT3 receptor and Selective serotonin reuptake inhibitor · See more »

5-HT7 receptor

The 5-HT7 receptor is a member of the GPCR superfamily of cell surface receptors and is activated by the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) The 5-HT7 receptor is coupled to Gs (stimulates the production of the intracellular signaling molecule cAMP) and is expressed in a variety of human tissues, particularly in the brain, the gastrointestinal tract, and in various blood vessels.

5-HT receptor and 5-HT7 receptor · 5-HT7 receptor and Selective serotonin reuptake inhibitor · See more »

The list above answers the following questions

5-HT receptor and Selective serotonin reuptake inhibitor Comparison

5-HT receptor has 233 relations, while Selective serotonin reuptake inhibitor has 206. As they have in common 27, the Jaccard index is 6.15% = 27 / (233 + 206).

References

This article shows the relationship between 5-HT receptor and Selective serotonin reuptake inhibitor. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »